Diethyl 1,4-dihydro-2,4,6-trimethyl-3,5-pyridinedicarboxylate
(Synonyms:3,5-二乙氧羰基-1,4-二氢-2,4,6-三甲吡啶;1,4-二氢-2,4,6-三甲基-3,5-吡啶二甲酸二乙酯;3,5-Diethoxycarbonyl-1,4-dihydro-2,4,6-collidine 3,5-二乙氧羰基-1,4-二氢-2,4,6-三甲吡啶;3,5-二乙氧基羰基-1,4-二氢-2,4,6-三甲基吡啶;紫外光敏处理液)
目录号 : KCM14645
CAS No. : 632-93-9
纯度 : ≥98%
Diethyl 1,4-dihydro-2,4,6-trimethyl-3,5-pyridinedicarboxylate (DDC) inhibits heme production by inhibiting ferrochelatase, the enzyme that catalyzes the addition of Fe to protoporphyrin IX to create heme B. Chronic DDC administration induces Mallory-Denk body formation, a feature of alcoholic and non-alcoholic hepatitis, and reduces IL-12A methylation in mouse liver.
Other Forms of Rapamycin:
KKL Med 的所有产品和服务仅用于科学研究，不能被用于人体，兽医，我们也不向个人提供产品和服务。
KKL 顾客使用本产品发表的 0 篇科研文献
暂无科研文献
| 分子式 |
C14H21NO4
|
| 分子量 |
267.3
|
| CAS号 |
632-93-9
|
| 中文名称 |
紫外光敏处理液
|
| 储存方式 |
-20°C
|
客服小K 
客服小K
Data Sheet
